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Scientists have expressed interest in interactions between nutrition and
the immune system for many years. Malnutrition is suggested by clinical
observations to lead to impaired immune responses associated with specific
nutrient deficiencies (Weller et al. 1998). Third-world countries and poorer
sections in westernized countries have had a high prevalence of nutrient
deficiencies. Additionally, a high prevalence of malnutrition can be found in
individuals who show nutritional problems as a result of systemic disorders:
cancer, chronic renal disease', burns, multiple trauma and chronic infections
(Weller et al. 1998). Ironically, obesity and excesses of nutrient intakes may also
result in reduced immune responses (Weller et al. 1998).
Some scientists suggest malnutrition works synergistically with infection to
intensify the outcomes of each other. This relabon can lead to many altered
immune responses with various levels of severity. The nutrient deficiency affects
immune function most consistently via changes in cell-mediated immunity and
cytokine production. The suppression in cell-mediated immunity is the result of a
reduction or a change in T-lymphocyte numbers and their corresponding
functions. In detail, T-Iymphocyte helper cells (CD4+) will not be available to B-
lymphocytes in adequate quantities (Weller et al. 1998). Lymphocyte
proliferation in response to stimulation will also decrease (Weller et al. 1998).
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Decreased cytokine production indirectly suppressed the rate of wound healing
(Weller et al. 1998).
Specifically our laboratory's attention has been directed towards iron
deficiency and dietary fat and their interrelationship with regards to immune
function. Iron is required for lymphocyte proliferation and for production of
antibodies by these cells (Connor and Beard 1997). Many enzymes with vital
roles in the immune system also require iron in order to properly function.
Studies indicate iron deficiency or overload can suppress immune function
(Helyar & Sherman 1992, Berger, Dyck, et al. 2000). Fatty acids are also
required for cell-mediated immunity (Gross and Newberne 1980). Diets
containing n-6 polyunsaturated fatty acids can suppress immune function;
whereas, diets containing n-3 polyunsaturated fatty acids can enhance immune
function (Gross and Newberne 1980).
Studies have found complications in identifying causative factors when
you not only consider the interactions of individual nutrients with immune
function; but, also with the nutrient-nutrient interrelationships in foods and in
dietary patterns (Mendola et al. 1995). Many factors that affect the bioavailability
of dietary iron have been studied extensively. For instance, factors that enhance
non-heme iron absorption are Vitamin C, MFP (Meat, Fish, and Poultry) factor,
lactic acid from foods and HCI from the stomach (Hallberg and Hulthen 2000)
Factors that reduce iron absorption are phytates and fibers, EDTA (in food
additives), calcium and phosphorous (milk) and tannic acid (found in teas)
(Hallberg and Hulthen 2000). Studies on factors influencing iron absorption
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(especially those trying to determine the meat factor) have generated interest in
fatty acids role in iron's bioavailability. There has been an association
demonstrated between dietary fat and iron on non-heme iron absorption, iron
status, and enterocyte aconitase activity (Droke and Lukaski 1996). The amount
of dietary fat and its degree of saturation can either enhance or suppress the
absorption and utilization of iron (Bowering et al. 1976) (Amine and Hegsted
1975) (Bowering et al. 1977). Because the relation between iron and immunity
may be confounded by dietary fat, it is important to identify correlates of iron and
dietary fat interactions on bioavailability to aid in the interpretation of their
interactions with the immune system.
The aim of this stUdy was to determine if the type of dietary fat;
monounsaturated, polyunsaturated or saturated, altered immune function in
growing rats deficient, adequate or overloaded in iron. We fed growing Sprague-
Dawley rats one of three dietary iron concentrations; deficient, adequate or high
in iron, in combination with one of four types of dietary fat; olive oil, safflower oil,
flaxseed oil, or beef tallow. The project determined if the ingestion of these fat
sources, typically consumed by humans and fed at a level recommended for
decreased risk of chronic diseases, enhanced immune function in iron deficient
rats or suppressed immune function in iron adequate or overloaded rats. The
study of these interrelationships can lead to insights into mechanisms for the role





Scientists have expressed interest in interactions between nutrition and
the immune system for many years. Malnutrition is suggested by clinical
observations to lead to impaired immune responses associated with specific
nutrient deficiencies (Weller et al. 1998). The nutrient deficiencies affect immune
function most consistently via changes in cell-mediated immunity and cytokine
production. Specifically our laboratory's attention has been directed towards iron
deficiency and dietary fat and their interrelationship with regards to immune
function.
In order to completely investigate the interrelationship between dietary iron
and fat with regards to immune function, the review of literature is divided into
sections: iron and lipid metabolism, review of immune function and the
importance of iron and lipids, and iron and lipid interactions. By looking at each
component separately, it will show more clearly the need for further research
regarding the roles of dietary iron and dietary fat in the modification of the
immune function.
Iron Metabolism
The remarkable and unusual details of iron metabolism have captivated
scientists for many years. Although iron is abundant on the earth, the prevalence
of iron deficiency is high (Hurrell 1997). Iron deficiency is of grave concern to
4
many scientists because of its' many biochemical functions in the body. Also,
there are negative outcomes associated with a deficiency state and an overload
state. Iron deficiency is associated with reduced work performance, greater
susceptibility to infections, and impaired neurological function (Marx 1997). Iron
deficiency though not desirable, does not have a lethal outcome. On the other
hand, iron overload diseases such as hemochromatosis are lethal and are
associated with iron-catalyzed oxygen radical damage (Marx 1997). This free
iron radical damage has been implicated in lipid peroxidation and ischemic
myocardial damage (Ascherio et al. 1994). These disorders stimulate
interdisciplinary studies between iron's nutrition, physiology, and biochemistry
(Latunde-Dada et al. 1998). To achieve the goal of controlling the incidences of
iron-associated disorders, a complete understanding of the chemical and
physiologic mechanisms that influence iron bioavailability is necessary (Latunde-
Dada et al. 1998).
There are four main aspects to stress when studying iron. First, even if
consumption of iron is adequate, only a small portion of it is actually absorbed
through the intestine and can be influenced by other dietary components.
Second, iron needs to be transported not just to form hemoglobin; but, to multiple
body compartments for various metabolic mechanisms. Third, the total storage
iron amount can vary widely without noticeable impairment of body function (Yip
and Dallman 1996). Lastly, red blood cells have a finite life span and need to
constantly be reproduced. The red blood cell turnover is responsible for most
iron turnover, but iron is not recoverable if the erythrocyte is lost from the body by
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bleeding externally. By briefly reviewing these four aspects of iron metabolism,
a strong foundation for the basis of iron's interrelationship with dietary fat can be
established.
The body regulates absorption of iron tightly because of potential damage
due to extra iron (Monsen 1999). There have been many studies that evaluated
the mechanisms that regulate iron absorption. Wein and Van Campen (1991)
state that the mechanisms that regulate iron absorption should either be present
at the mucosal surface or influence the chemical state of iron before contact with
the mucosal surface. Hunt and Roughead (1999) provide further support for the
hypothesis made by Ehtechami and Elsenhans (1989) that the mucosal cells in
the upper small intestine regulate iron absorption. Proposed mechanisms for
uptake of iron at the cell surface include a plasma membrane oxido-reductase
mechanism (Thorstenesen 1988). There has also been a proposal of transferrin
endocytosis from the serosal side of the intestine (Huebers et al. 1983). Current
research indicates iron must be reduced before it can be absorbed (Wollenberg
and Rummel 1987). Their findings show the need for a necessary reducing
factor, which can be ascorbic acid and/or a reductase enzyme in the apical
membrane of the mucosal epithelium. Specific genes involved in the iron uptake
and transport by mucosal cells have been identified by experimental studies with
genetically anemic mice and anemic Belgrade rats. The gene Nramp2, now
referred to as divalent metal iron transporter 1 (DMT1), is located on the apical
membrane of the enterocyte (Andrews et al. 1999). It presumably delivers iron to
cell compartments where it undergoes endocytosis to be transported to the
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basolateJal membrane (Fleet 2000). Also, glycosylphosphatidylinositol (GPI)-
anchored ceruloplasmin, which acts as a copper-dependent oxidase, has been
suggested to work together with a putative basolateral iron transporter to control
the exit of iron out of the enterocyte (Wood and Han 1998).
Regardless of the mechanism, researchers agree absorption can be
influenced by dietary iron, which can be in two forms. heme and non-heme iron
(Hallberg and Hulthen 2000). Heme iron, the most functional and effectively
absorbed (Beard et a!. 1996) makes up proteins like hemoglobin with an iron-
porphyrin prosthetic group (Yip and Dallman 1996). Non-heme iron consists
mainly of iron salts (Yip and Dallman 1996). Absorption of non-heme iron is
based on the solubility of the iron salt compound (Yip and Dallman 1996).
Characteristics of common iron salts are divided into four groups (Hurrell 1997):
those that are freely water-soluble; those that are poorly water soluble, but
soluble in dilute acids; those that are water soluble, but poorly soluble in dilute
acids; and those that the iron compound is protected. Generally, the freely
water-soluble salts and the water insoluble but soluble in dilute acids are highly
bioavailable in rats (i.e. ferric citrate) (Hurrell 1997). Salts that are poorly soluble
in dilute acid have only a low to moderate bioavailability (Hurrell 1997).
Hallberg and Hulthen (2000) suggest the variation in iron absorption from
diets is due more to differences in the bioavailability of the iron, which can lead to
a >10 fold variation in iron absorption, than to a variation in iron content.
Enhancers of iron absorption (e.g. ascorbic acid, vitamin A, p-carotene, meat,
fish, and poultry) increase the bioavailability of iron from meals (Reddy et al.
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2000). Inhibitors of iron absorption (e.g. inositol phosphates, calcium, and
certain structures in polyphenols) decrease the bioavailability of iron from meals
(Reddy et al. 2000). Because of the continually expanding list of dietary factors
that enhance or inhibit the bioavailability of iron, prediction of iron absorption from
a meal is increasingly difficult. Methods that approach the problem include in
vitro measurements of food iron bioavailability, such as dialyzable iron or iron
uptake in the Caco-2 cell culture model (Reddy, Hurrell, and Cook 2000).
Many studies have observed the effect of specific dietary constituents on
iron absorption; but these are single-meal or short-term bioavailability studies.
Over a longer period of time the effects of dietary constituents on iron absorption
may be negated by adaptive mechanisms (Minihane and Fairweather-Tait 1998).
In long-term iron status, the principle determinant of the efficiency of iron
absorption is the amount of storage iron. For instance, if iron stores are high,
then iron absorption is low. Conversely, if iron stores are low, then iron
absorption is high (Fleet 2000). This observation raises speculation that there is
genetic regulation of both heme and non-heme receptors and binding proteins
(Beard et al. 1996). Others have proposed that intestinal mucosal ferritin stores
iron that is not transferred to the plasma and then is lost when the enterocyte is
shed (Monsen 1999). Thus, there is a mechanistic explanation for feedback
regulation of iron absorption: an adequate iron status increases quantities of iron
held by the enterocyte.
Iron absorption is also influenced by the rate of erythrocyte production.
Erythrocytes have a mean lifespan of about 120 days in humans (Beard et al.
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1996). At the end of the lifespan, they are catabolized by Kupffer cells and
spleen macrophages (Beard et al. 1996). Active erythropoiesis enhances iron
absorption (Beard et al. 1996) and thus, may be an endogenous signal for iron
absorption.
Evaluation of iron absorption in humans is complicated for a variety of
reasons (Latunde-Dada et al. 1998). Iron absorption equipment is expensive and
is not within the range of most laboratories, even in developed countries. Thus,
animal models have been used. Opposing views highlight the differences
between iron metabolism in rats and humans. Rats have a greater mucosal cell
turnover leading to greater iron losses. Iron absorption in rats is also more
dependent on serum iron levels than on internal iron turnover or iron stores, as is
the case in humans (Latunde-Dada et al. 1998). However, studies on iron
deficiency progression have to subject the patients to repeated phlebotomies
because dietary iron deficiency in adults progresses too slowly to lend itself
readily to experimental observation (Dallman et al. 1982). Also the collection of
solid tissue samples is rarely justifiable in man. Nevertheless, pilot studies with
animal models provide the flexibility to manipulate different variables involved in
the finding of mechanisms for food iron availability and absorption (Latunde-Dada
et al. 1998). The use of growing male rats, in combination with a low iron diet,
eliminates female hormone fluxes that may interfere with homeostasis and
provides a method for generating iron deficiency via dietary manipulation.
The second aspect to stress when studying iron is it's need to be
transported not just to form hemoglobin; but, to various body compartments for
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various metabolic mechanisms. To reduce the toxic effects of iron accumulation,
iron must move safely from the site of absorption to sites of utilization. The
metabolic safety solution is to use the transport protein transferrin (Andrews et al.
1999). Transferrin delivers iron to tissue cells by binding to surface expressed
transferrin receptors (Chen et at. 1998). Receptor-mediated endocytosis
transports the complex to the cytoplasm where the iron is released and the
transferrin is recycled to the plasma membrane (Chen et al. 1998). Studies
indicate transferrin receptors are found in abundance on erythroid precursors as
well as placental cells (Andrews et al. 1999). If transferrin saturation is low, then
iron stores are deficient; and conversely, if there is high transferrin saturation,
then there is an indication that iron stores are high (Yip and Dallman 1996),
The third aspect to stress is the amount of total storage iron. Total
storage iron amount can vary widely without noticeable impairment of body
function (Yip and Dallman 1996). Storage iron is found in two forms: as ferritin,
a soluble protein-enveloped core, and as hemosiderin, which is insoluble (Aisen
and Listowsky 1980). Ferritin-bound iron is more biologically I biochemically
available than hemosiderin-bound iron (Beard et al. 1996). Most of the storage
iron is found in the liver, reticuloendothelial cells, and the bone marrow (Beard et
a!. 1996). It serves mainly as a reservoir to supply cellular iron needs such as
hemoglobin production (Yip and Dallman 1996). In the sequence of development
of iron deficiency in the rat, iron stores can be depleted before anemia is
diagnosed (Dallman et al. 1982).
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Lastly. red blood cells have a finite life span (-120 d) and need to
constantly be reproduced. The red blood cell turnover is responsible for most
iron turnover, but iron is not recoverable if the erythrocyte is lost from the body
through external bleeding. Disruptions in iron turnover can be seen during
menstruation, pregnancy, and gastrointestinal bleeding (Beard et al. 1996). To
meet the needs of tissue, iron must be removed from storage, dietary iron
absorption must be enhanced, or recycled from the process of red blood cell
turnover (Beard et a!. 1996).
Lipid Metabolism
Dietary fat and its role in metabolism has been studied extensively for
many years. The high prevalence of studies looking at fat can be contributed to
the global relation between nutrition and health. To effectively consider why the
influence of fat is important, two different points of view need to be considered:
quantity and quality (Bagger et al. 1996). Quantity views are based on
developed societies with high levels of dietary fat intake and the health risks
associated with high dietary fat intake. Quality views are based on the possible
implications of the type of fat on an individual's health (Seiquer et al. 1995). It is
these quality views that recent research emphasizes. Studies show the influence
of different dietary fat sources on serum lipid levels, lipid plasma concentration,
and their relationship to coronary heart disease (Seiquer et al. 1995). The type
of dietary fat can also influence the fatty acid composition of different lipid
fractions, which is important for eicosanoid synthesis that may influence platelet
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aggregation, bleeding time, blood pressure, inflammatory prooesses and
atherogenesis (Seiquer et al. 1995). Because coronary heart disease remains a
leading cause of death in developed countries, dietary fat metabolism should be
given a high priority in research.
Lipids have important metabolic roles. One such role is their ability to be
oxidized to provide energy (Welch and Borlak 2000). Another role for lipids is to
serve as precursors for active substances such as prostaglandins, steroid
hormones and bile acids (Welch and Borlak 2000). Because of the important
roles dietary fat play, a reduced or amplified amount of fat (such as diets high in
saturated fat) can lead to problems in lipid metabolism, such as the development
of atherosclerosis (Seiquer et al. 1996).
Dietary fat absorption is a multistage process, which is complicated by its
insolubility in aqueous medium (Nelson and Ackman 1988). Short chain length
fatty acids are usually esterified and released from triacylglycerols in the stomach
and small intestine. Then they are bound to albumin to be transported via the
portal vein to the liver (Welch and Borlak 2000). Long-chain fatty acids are then
absorbed by passive diffusion in the form of a micelle (negatively-charged
aggregates of the digested free fatty acids together with the bile salts) into the
enterocytes (Welch and Borlak 2000). In the cell, the lipolysis products are then
re-esterified to synthesize triacylglycerols, phospholipids or cholesteryl esters
(Nelson and Ackman 1988). At this point, the enterocyte transports the lipid out
of the cell and into the lymph by binding de novo synthesized apolipoproteins
with the lipid to form a lipoprotein (chylomicron) that is aqueously soluble (Welch
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and Borlak 2000). The chylomicron can then transport the long-chain fatty acids
via the lymphatic system until they reach a point of entry into the bloodstream.
The bloodstream then carries the lipids to the rest of the organs (Nelson and
Ackman 1988).
The lipoprotein structures that transport the lipids are classified by
differences in their hydrated densities: very low density lipoprotein (VLDL);
intermediate-density lipoprotein (IDL); low-density lipoprotein (LDL); and high-
density lipoprotein (HDL) (Welch and Borlak 2000). The role of HDL is to carry
cholesterol from peripheral tissues to the liver where it is catabolized and
excreted (Chen et al. 1995). The role of LDL is to carry cholesterol to the
peripheral tissues and to regulate de novo synthesis of cholesterol at those sites
(Chen et al. 1995). Keep in mind the most important motive for the extensive
research on dietary fat is that of hypercholesterolemia as an important co-factor
in the development of coronary heart disease (Seiquer et al. 1995). Changes or
modifications to the lipoprotein's structure and composition (especially LDL) by
the different types of fatty acids making up the chylomicron, are thought to affect
their atherogenic potential (Seiquer et al. 1995). Low-density lipoprotein particles
made up of cholesterol esterfied with saturated fatty acids, had reduced binding
capabilities, internalization and degradation by fibroblast cultures compared with
LDL particles made up of cholesterol esterfied with polyunsaturated fatty
acids(Seiquer et al. 1995).
The LDL particle may also go through compositional changes that
increase its atherogenic potential (Seiquer et al. 1995). The common initiating
13
step for .compositional changes is the peroxidation of polyunsaturated fatty acids
that make up the LDL (Seiquer et al. 1995). The more recognizable oxidized
LDL can be scavenged by macrophages and accumulate in the lymphoid tissue
cells which leads to fatty streak formation. The fatty streak is the earliest
recognizable lesion for atherogenesis (Seiquer et al. 1995).
A reduction in serum lipid levels has reduced the amount of lipids
available for peroxidation and reduced the risk for atherosclerosis. Even though
there have been several drug therapies placed on the market to lower serum
cholesterol values, the National Cholesterol Education Program advocates
lifestyle dietary modification as the primary treatment for lowering cholesterol
values (Ordovas 1999). Currently, the recommended dietary modifications
include, lowering the quantity of total fat intake to less than 30% of energy,
lowering the amount of saturated fat intake to less than 10% of energy, and
lowering the amount of cholesterol intake to less than 200 mg/d along with a
greater consumption of dietary fiber and complex carbohydrates (Ordovas 1999).
However, controversy in recent research shows lowering of total fat intake may
not be the only answer, rather reducing the consumption of saturated and trans
fats can lead to a regression in atherosclerotic lesions (Ordovas 1999, Conner et
al. 1997, Katan et al. 1997). The controversy arises from the variability in
response of serum cholesterol to diet between subjects. Because of the
variability in responses in human studies, primarily due to the lack of information
regarding the heritability of the response to dietary intervention, animal studies
are used in today's research of dietary lipids (Ordovas 1999). The variability in
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the serum lipoprotein response to dietary manipulation may have a significant
genetic component (Ordovas 1999). Despite this uncertainty, studies have
focused their attention on the influence of the type of dietary fat on plasma lipid
levels.
Epidemiological and clinical study results have helped fuel the awareness
that saturated fats are a risk factor for coronary heart disease (Edionwe and Kies
1998). Saturated fats raise serum total cholesterol (TC), and serum LDL and may
lower serum HDL (Edionwe and Kies 1998). For some countries; however,
unsaturated fats are not affordable by the majority of the people. Saturated fats
are cheaper and are still the preferred dietary source (Edionwe and Kies 1998).
New studies are thus needed to demonstrate differences in saturated fats. For
example, not all saturated fats have similar effects on serum TC or cholesterol in
the different lipoproteins (Edionwe and Kies 1998). Such saturated fats contain
medium-chain fatty acids like caprylic acid and caproic acid, which have been
shown not to raise serum cholesterol levels when compared with palmitic acid
(Denke and Grundy 1991). Early evidence suggested and has been confirmed
that the same holds true for stearic acid (Bonanome and Grundy 1988). Dietary
fats rich in stearic acid are beef tallow and cocoa butter (Denke and Grundy
1991). Hydrogenated vegetable oil contains considerable amounts of trans fatty
acids, which were recently shown to have adverse effects on serum cholesterol
profiles (Sundram et al. 1992). Palmitic acid is considered to raise cholesterol
levels causing hypercholesterolaemia (Sundram et al. 1992).
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Because polyunsaturated fatty acids (PUFAs) are known to lower blood
cholesterol levels, research in PUFAs .has increased (An et al. 1997). Most
research has focused on n-6 and n-3 PUFAs. N-6 fatty acids, such as those
found in safflower oil, lower serum cholesterol levels, but not tri8cylglycerols (An
et al. 1997). N-3 fatty acids, such as those found in flaxseed oil, lower serum
cholesterol, and lower serum triacylglycerols even more in experimental animal
studies (An et al. 1997). Some n-3 fatty acids may reduce the levels of serum
lipids and modify membrane fatty acid composition, thus decreasing the
incidence of atherosclerosis and thrombogenesis. Fatty acid composition is also
important for oxidative stability of food oils (Lu et al. 1997). Because
polyunsaturated fats are high in both linoleic and linolenic acids they are
relatively susceptible to oxidation (Lu et al. 1997).
Flaxseed oil, contains about 60% a-linolenic acid (ALA) (Kelly et al. 1993).
Longer chain n-3 fatty acids (ones with 20 carbons) have a stronger effect on
lowering blood lipids and in deposition of longer chain n-3 fatty acids into tissue
lipids than ALA (An et al. 1997). Previous studies have shown that humans have
a limited capacity to convert ALA to eicosapentaenoic acid (EPA) and
docosahexaenoic acid which could explain the lesser effect in reducing blood
lipids than longer chain n-3 fatty acids (Kelly et al. 1993). Eicosapentaenoic acid
and docosahexaenoic acid are believed to lessen the tendency for platelet
aggregation and thrombosis (Allman et al. 1995). A mechanism that is proposed
whereby long chain n-3 fatty acids inhibit platelet aggregation is via suppressed
production of the platelet prostaglandin thromboxane A2 (TXA2), an eicosanoid
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(Allman et al. 1995). Arachidonic acid (AA) is the usual substrate for TXA2
production (Allman et al. 1995); however, EPA can replace AA thus reducing
TXA2production and thrombotic potential. Some studies suggest ALA is
metabolized to EPA by desaturation and chain elongation; but, the efficiency of
the conversion limits the ability to also reduce TXA2 production (Allman et al.
1995). However, an opposing study indicates ALA enhancs platelet EPA
sufficiently to alter platelet function in a positive way (Allman et al. 1995).
Platelets play an essential role in thrombosis and atherosclerosis, but the
confounding research and the mechanisms for the effects of dietary oils on
platelet function are not well understood.
The peroxidative capacity of polyunsaturated fatty acids is a concern of
nutritionists because free radicals cause tissue damage. Because of this,
studies have focused on monounsaturated fatty acids and their lower
susceptibility to peroxidation (Adamopouloa et al. 1996, O'Connell and Peters
1997). A reduced susceptibility to peroxidation reduces free radical production
(O'Connell and Peters 1997).
Studies also have shown a potential protective role for monounsaturated
fatty acids via their ability to lower TC and LDL to a greater extent than
polyunsaturated fatty acids (Adamopouloa et al. 1996, O'Connell and Peters
1997). High-density lipoprotein concentrations were greater in volunteers on
monoullsaturated diets compared with those on polyunsaturated diets
(Adamopouloa et al. 1996). Monounsaturated fatty acids also lowered
triacylglycerols compared with diets rich in saturated fatty acids (Kris-Etherton et
17
al. 1998). Triacylglycerols may not be an independent risk factor in coronary
heart disease because any effect of triacylglycerols tends to be eliminated once
HDL levels are taken into account in multivariate analysis (Adamopouloa et al.
1996). However, triacylglycerols are still considered a risk factor in recent
guidelines from the European Atherosclerosis Society (Adamopouloa et al.
1996). Olive oil is the primary food source of monounsaturated fatty acids (Kris-
Etherton et al. 1998).
Dietary fatty acid composition and dietary cholesterol influence circulating
cholesterol concentrations. The impact of dietary cholesterol on circulating
cholesterol concentrations is controversial (Jones et al. 1994). Some studies
indicate no effect (Kestin et al. 1989, Keys et al. 1956, Slater et al. 1976) while
others indicate a cholesterol raising effect (Jones et al. 1994, Connor et al. 1964,
Mattson et al. 1972, Keys 1984). In animal studies, a greater dietary sterol
consumption reduced cholesterol synthesis (Jones et al. 1994, Anon 1987,
Dietschy and Siperstein 1967). In humans, the degree of saturation of dietary fat
had no effect on the synthesis of cholesterol, whereas the addition of dietary
cholesterol to the diet resulted in a reduction in fractional absorption and
inhibition of cholesterogenesis (Jones et al. 1994, McNamara 1987). Because
coronary heart disease remains a leading cause of death in developed countries;
dietary fat metabolism should be given a high priority in research.
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Immune Function
Scientists have expressed interest in interrelationships between nutrition
and the immune system for many years. Inadequate nutrition leads to impaired
immune responses associated with specific nutrient deficiencies (Weller.
Lockwood, et al. 1998). These nutrient deficiencies affect immune function most
consistently via changes in cell-mediated immunity and cytokine production.
A brief overview of the basic concepts of cell-medicated immunity and
cytokine production will help to provide plausible explanations for the
experimental study to follow. To study the human immune system, one can
choose a species of mammal that will reasonably depict humans' immune
responses. A rodent model has been suggested to be more similar to human
responses (Davis and Hamilton 1998). When comparing mammalian species'
immune systems they are similar but not identical (Davis and Hamilton 1998).
Significant differences were noted: in the expression of MHC class II molecules,
in leukocyte differentiation molecules, and in the composition of the immune
system (Davis and Hamilton 1998). The largest differences in immune functions
were found in pigs, cats, ferrets, and horses compared with humans and rodents
(Davis and Hamilton 1998;Holmes and Lunn 1994;Lunn et al. 1993;Lunney and
Pescovitz 1987;Pescovitz et at. 1984). These differences in immune function
and composition of the noted species highlight the rodent's immune system as
the most analogous to humans for cell-mediated immunity and cytokines.
The cells of the immune system are derived from bone marrow
hematopoietic stem cells (Boissonneault 2000). These stem cells develop into
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neutrophils, eosinophils, and basophils, monocytes, and B- and T-lymphocytes
(Boissonneault 2000). Neutrophils function as efficient phagocytic cells
(Boissonneault 2000). Basophils have high quantities of cytoplasmic granules
that help to mediate immediate hypersensitivity reactions, including an allergic
response (Boissonneault 2000). Upon migration into tissues from the
bloodstream, monocytes differentiate into macrophages (Boissonneault 2000).
Macrophages remove debris and serum proteins by use of their highly
phagocytic nature (Erickson 1998). They can also kill tumor cells, defend against
infectious agents and mediate and respond to inflammation (Erickson 1998).
More importantly monocytes and macrophages produce regulatory molecules
called cytokines (soluble factors), which influence activities of lymphocytes by
acting as intercellular mediators of the immunological response (Boissonneault
2000). T-Iymphocytes, which mature in the thymus, serve as mediators in
immune response regulati.on and as mediators of delayed-type hypersensitivity
and effectors of T-Iymphocyte mediated cytotoxicity (Boissonneault 2000). B-
lymphocytes, which mature in the bone marrow in adults, serve as producers of
antibodies in a humoral immune response (Boissonneault 2000).
Human malnutrition and excess nutrient intake can reduce cell-mediated
immune responses (Chandra 1997). A very common example is that of protein-
energy malnutrition (PEM). The thymus is decreased in size and weight
(Chandra 1997). This leads to fewer lymphoid cells, not only in the thymus but
also around small blood vessels, in the spleen and in the lymph nodes (Chandra
1997). The reduchon in lymphocytes includes mature helper T lymphocytes and
20
mature cytotoxic T lymphocytes. Lymphocyte proliferation and DNA synthesis
are also suppressed, which may be the result of loss of essential nutrients or
inhibitory factors (Chandra 1997). Phagoc,ytosis and the production of several
cytokines in humans with PEM are also suppressed (Chandra 1997).
Human malnutrition is usually a complex condition of multiple nutrient
deficiencies. Because a single nutrient deficiency is rare, observations of single
nutrient interactions with the immune system are limited to laboratory animals
deprived of one dietary element (Bendich and Chandra 1990). These
observations have confirmed the vital role of several vitamins and trace elements
in immunocompetence (Chandra 1997).
Early evidence has established that the cytokines produced by the
immune system not only regulate immune function, but also modify the growth
process (Spurlock 1997). Now it is also apparent that cytokines mediate a direct
regulation of nutrient metabolism and growth (Spurlock 1997). Additionally,
cytokines may interact with other modulators of the immune system such as
glucocorticoids, prostaglandins, and catecholamines, all of which may affect
cellular metabolism (Spurlock 1997). For example, insulin-like growth factor I
(IGF-I), is believed to be essential for T lymphocyte proliferation (Savendahl and
Underwood 1997). Specific cytokines that make up a cytokine profile when being
assessed by researchers are interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-
10 (IL-10), and interferon-y (IFN-y) (Mosmann and Coffman 1989). Cytokines
can control immune responses by influencing and changing the balance of T-
helper 1 (Th 1) and T-helper 2 (Th2) cells (Von Ruecker and Schmidt-Wolf 2000).
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By measuring this cytokine profile, a more accurate measurement of the T helper
lymphocyte (Th1ffh2) b.alance can be determined (Von Ruecker and Schmidt-
Wolf 2000). T helper lymphocytes are subsets of T-Iymphocytes, which are
activated by antigen presenting macrophages, and are essential for further
development and organization of the immune response (Von Ruecker and
Schmidt-Wolf 2000). T-helper 1 cells function to induce activation of cell-
mediated immunity (including activation of cytotoxic T-Iymphocytes and delayed-
type hypersensitivity reaction) (Von Ruecker and Schmidt-Wolf 2000). T-helper 2
cells function to induce the humoral arm of the immune response (Von Ruecker
and Schmidt-Wolf 2000). By determining the Th1ffh2 balance a more precise
evaluation of catabolism as well as metabolic stress can be determined (Von
Ruecker and Schmidt-Wolf 2000).
Interleukin-2 is an important cytokine in the regulation of the immune
system and is produced by T helper-1 (Th1) lymphocytes (Feldmann 1998).
Interleukin-2 has enhanced the proliferation of phytohemagglutinin P-stimulated
peripheral blood mononuclear cells (Savendahl and Underwood 1997).
Interleukin-2 is also known to have a role in stimulating T-lymphocyte
proliferation and differentiation, as well as the activation of cytotoxic lymphocytes
and macrophages (Feldmann 1998). Recently, a report demonstrated IGF-I-
stimulated IL-2 production in human peripheral T lymphocytes (Savendahl and
Underwood 1997). A fasting state can depress serum IGF-I production, thus
possibly leading to reduced IL-2 production. This suggests a possible role for IL-2
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and IGF-I in maintaining normal natural killer cell (NK cells) cytotoxicity
(Savendahl and Underwood 1997).
Interleukin-4 is also an important cytokine for the growth of T-Iymphocytes,
but not to the extent of IL-2. Interleukin-4 is produced by T-helper-2 lymphocytes
(Th2) and stimulates B cell proliferation and production of immunoglobulins (Ig),
specifically IgE and IgG1 (Feldmann 1998). At the same time, IL-4 stimulates
proliferation of TH2 lymphocytes, which will enhance production of IL-10.
Interleukin-10 inhibits production of IL-1, TNF-alpha and other pro-inflammatory
cytokines (Feldmann 1998).
Interferon-y (IFN-y) is a cytokine produced primarily by activated Th1
lymphocytes and NK cells (Feldmann 1998). It helps to induce and enhance the
development of more Th 1 lymphocytes and suppresses Th2 immune responses
(Von Ruecker and Schmidt-Wolf 2000). Interferon-y does provide antiviral and
anitproliferative activities; but, not to the extent of IFN-a and -~ (Feldmann 1998).
It is however. the most important inducer of macrophage activation, which favors
the development and activities of Th1 lymphocytes (Feldmann 1998).
Corticosteroids secreted from the pituitary help to stimulate Th2
lymphocytes to produce IL-10. Interleukin-10's primary role is to control the type
of immunological response by T-Iymphocytes. It predominantly inhibits the
production of IFN-y and other Th-1 cytokines (Von Ruecker and Schmidt-Wolf





Iron deficiency is a worldwide nutrient deficiency, and is consistently
associated with morbidity and infectious diseases (Berger et a!. 2000). Iron is
required for the synthesis of hemoglobin, myoglobin, and certain essential
enzymes; a deficiency leads to anemia (Wan et al. 1989). Malnourished patients
with anemia and inflammation have greater levels of free iron in conjunction with
lower concentrations of serum transferrin, which leads to a greater susceptibility
to bacterial pathogens (Wan et aI., 1989). Lack of iron reduces an individual's
resistance to pathogens through impairment of immunocompetence, more
specifically through cell-mediated immunity (Berger et al. 2000).
Iron deficiency causes multiple immune functions to be compromised.
One such compromise is the production of fewer NK cells associated with
reduced interferon production (Scrimshaw and SanGiovanni 1997). Another
compromise is reduced numbers of B-Iymphocytes in spleens of anemic mice
(Helyar and Sherman 1992). Stimulation and proliferation of lymphocytes are
also compromised by iron deficiency (Scrimshaw and SanGiovanni 1997). Both
the proportion of T-Iymphocyte subsets and the absolute number of T-
lymphocytes were reduced with iron deficiency anemia (Walter et a!. 1997). The
lymphocyte response to concanavalin A (ConA) antigen was impaired in iron
deficiency giving rise to a significant correlation between the stimulation index
and transferrin saturation (Walter et al. 1997). Another function that is
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compromised by iron deficiency is phagocytic killing power (Scrimshaw and
SanGiovanni 1997). Iron serves as the generator of free oxygen radicals in the
phagocytic cells (Beisel 1996). Lastly, iron deficiency also suppressed the
bactericidal activity of neutrophils (Connor and Beard 1997).
Discussion of iron and immunity would not be complete without an
introduction to iron overload and infection. Iron overload is a disorder of iron
metabolism resulting from either excess dietary iron absorption or parental iron
loading (Wu et al. 1990). In most instances, iron overload is a genetic disorder
called hemochromotosis. It leads to the accumulation of iron in tissues, which
results in hepatocellular damage and fibrosis leading to cirrhosis (Wu et aI.1990).
Iron overload can also be toxic, which promotes peroxidative damage to lipid
membranes (Wu et al. 1990).
~ '
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Iron overload, unlike iron deficiency, helps the infectious agent. Iron is not ~
only needed by the host to fight infection, but also by the infectious agent for
growth (Scrimshaw and SanGiovanni 1997). A protective effect can be shown by
the lack of available iron (iron deficiency) for agent replication (Scrimshaw and
SanGiovanni 1997). Ferritin also functions as an iron-withholding mechanism
(Scrimshaw and SanGiovanni 1997). High levels of splenic ferritin have been
reported to suppress lymphocyte transformation (Wu et al. 1990). For example,
adding ferric salts or ferritin to human peripheral blood mononuclear cell cultures
suppressed mitogenic responses (yVu et al. 1990). The extent of this effect is
also dependent on the chemical structure of iron (Wu et al. 1990). Acid
isoferritins have a greater immunosuppressive effect on T-Iymphocytes than do
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basic isoferritins 0Nu et al. 1990). Transferrin, an iron-binding protein, is found
not only in the blood but also in all body fluids and is the standard mechanism for
withholding iron from the infectious agent (Scrimshaw and SanGiovanni 1997).
The more saturated transferrin is with iron I the less competent it is to provide
protection from infection (Connor and Beard 1997). Iron overload induces this
high serum ferritin and transferrin level that impairs immunity (Wu, Meydani,
Meydani, Burklund, Blumberg, and Munro 1990). To withhold iron may
compromise the host's immune function. Wu et al. (1990) state that a high iron
diet given to young rats (4 months of age) for four weeks increased ConA-
stimulated lymphocyte proliferation. Wu et al. (1990) did not see this same effect
for older rats (19-22 months of age). It is Vitally important to recognize that iron
intake has a narrow range over which the immune system can function normally.
Lipid and Immunity
Numerous studies indicate dietary fat can affect immune function. Dietary
fats can influence membrane phospholipid composition (Wu and Meydani 1998)
and changes in phospholipid composition are believed to playa large role in
alterations of immune function either by membrane-bound enzyme activity or by
fatty acid precursors of immune-modulating eicosanoids (prostaglandins,
prostacyclines, thromboxanes, leukotrines) (Beisel 1996). For example, studies
have shown that polyunsaturated fatty acids modify lymphocyte membrane
fluidity resulting in altered receptor function that could influence the generation of
intracellular second messengers (Hagve 1988).
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T- and B-Iymphocyte functions are influenced by dietary fat saturation. B-
lymphocyte responses to mitogens or pathogens do not appear to be influenced
as greatly as T-Iymphocytes by the dietary fat level or degree of saturation
(Boissonneault 2000). It is also known that the type and degree of saturation of
fat can alter cytokine production. Dietary fat may alter the ability of macrophages
to kill tumor cells, possibly by a mechanism that involves prostaglandins
(Erickson 1998). Macrophages kill tumor cells by their secretion of the soluble
inflammatory mediator tumor necrosis factor-a (TNF-a) (Erickson 1998).
Cytotoxic responses are also influenced by dietary fat saturation (Erickison
1984).
It is well known and documented that saturated fats raise serum total
cholesterol and lDl and may lower HOl (Edionwe and Kies 1998). These effects
of saturated fat lead to the awareness that increased consumption of saturated
fatty acids leads to increased risk factors for coronary heart disease and the
development of atherosclerosis (Edionwe and Kies 1998). The increased risk for
atherosclerosis associated with saturated fatty acids may be the result of a
compromised immune function via alterations in macrophage functions
(Boissonneault 2000). Macrophages contain receptors for lipoproteins such as
lOl and VLOl as well as scavenger receptors that engulf oxidized lipoproteins
(Boissonneault 2000). lron.ically, macrophages are also partially responsible for
oxidative modification of lOl, which is dependent on oxygen radical production
(Boissonneault 2000). Patients with atherosclerosis have increased cytokine
levels such as Il-2, Il-1, TNF-a and transforming growth factor-~ (TGF-~)
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(Merendino et al. 1998). There is also evidence indicating the availability of
cholesterol is an important determinant for the capacity of lymphocyte
proliferation, which directly establishes a relation between cholesterol level and
T-lymphocyte proliferation (Merendino et al. 1998). It has been demonstrated
that oxidized LDLs significantly reduce and inhibit ConA-induced lymphocyte
proliferation (Merendino et al. 1998).
Deficiency of the essential fatty acids (linoleic and linolenic) also alters
immune function (Boissonneault 2000). Immune cell phospholipid membranes
contain a high accumulation of PUFA 0Nu and Meydani 1998). The functions of
lymphocytes are highly dependent upon phospholipid membrane associated
actions 0Nu and Meydani 1998). It is conceivable, therefore, to recognize that
changes in the PUFA content of lymphocyte membranes will alter functions such
as the secretion of cytokines and lymphocyte transformation 0Nu and Meydani
1998).
Dietary n-6 PUFAs, such as those from safflower oil, modify lymphocyte
structure and function via changes in membrane fluidity, receptor binding sites,
hormonal signal transduction, and the lymphocyte reaction to surface antigen
presentation (Wan et al. 1989). N-6 PUFAs also are believed to affect generall
properties of lymphocytes indirectly by acting as precursors for the production of
lipid mediators (eicosanoids) (Wan et al. 1989). Excess dietary consumption of
Iinoleate (n-6 PUFA) may also enhance tumorigenesis and suppress the
response of spleen lymphocytes to mitogens, such as ConA (Wan et al. 1989).
Furthermore, n-6 PUFAs have been associated with greater production of
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prostaglandin E2 (PGE2) (VVan et aI., 1989). Prostaglandin E2 can inhibit
lymphocyte proliferation, macrophage collagenase synthesis, NK activity, and
production of interferon and other Iymphokines by T-Iymphocytes (Wan et aI.,
1989).
N-3 PUFAs, from sources such as flaxseed oil, can also alter membrane
structure and function of lymphocytes. Cytotoxicity of cytotoxic T-Iymphocytes
can be enhanced with the incorporation of PUFA into the diet whereas; saturated
fatty acids suppress the activity by reducing membrane fluidity and receptors
(Fritsche and Johnston 1989). The consumption of diets rich in n-3 PUFA can
also reduce the production of PGE2 (a pro-inflammatory eicosanoid, which
depending on the dosage can be quite inhibitory) because of the direct
competition for enzymes in the eicosanoid synthesizing pathway (Fritsche and
Johnston 1989). In comparison to n-6 PUFAs, n-3 PUFAs, eicosapentaenoic
and docosahexaenoic, tend to be more immunosuppressive, which for patients
with cardiovascular, autoimmune and inflammatory diseases is beneficial (Jeffery
et al. 1996, Kromann and Green 1980, Calder and Newsholme 1992). However,
excessive reduction in eicosanoids and cytokines could impair normal host
defense mechanisms or homeostasis within the patient 0Nu and Meydani· 1998).
N-3 PUFAs can also suppress the immune response by inhibiting lymphocyte
proliferation, IL-2 production, NK cell activity, and antigen presentation (Jeffery.
et al. 1996, Jolly, et al. 1997). One study also indicated the administration of fish
oil (an n-3 source) suppressed the serum levels of IL-6, IL-8, IL-10, and TNF-a
compared with rats fed safflower oil (Tashiro et al. 1998). Another study
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supported the results by demonstrating a reduction in IL-4 and Il-10 production
in mice fed fish oil compared with mice fed a low-fat diet (Yaqoob and Calder
1995). Although a reduction in the pro-inflammatory eicosanoids and cytokines
may be beneficial for patients with cardiovascular. autoimmune and inflammatory
diseases, excessive reduction could impair normal host defense mechanisms or
homeostasis within the patient 0Nu and Meydani 1998).
Oleic acid an n-9 fatty acid family member found in high concentrations in
olive oil also alters membrane structure and function of immune lymphocytes.
One study concluded that oleic acid affects immune function in a similar way to
n-3 fatty acids (Perez et a!. 1989). Oleic acid suppressed the spleen T-
lymphocyte proliferation response to cell surface antigens but elevated the
response five-fold when cultures were enriched with control macrophages (Perez
et a!. 1989). The main advantage oleic acid has over PUFAs is oleic acid does
not oxidize easily; thus. there is a lower consumption of immunosuppressive
oxidized lipids available to damage cells (Boissonneault 2000).
Iron and Lipid Interactions
Research needs not only to consider the interrelationship of nutrients with
immune function; but, also with the nutrient-nutrient interrelationships in foods
and in dietary patterns (Mendola et al. 1995). Many dietary components can
influence iron metabolism; specifically vitamin C, copper and zinc (Hallberg
1981). These interactions of iron with other micronutrients have been studied
extensively. However, the interactions of iron and macronutrients are less well
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defined (Johnson et al. 1987). In particular, the interaction between iron and
dietary fat is vague.
Known interactions of micronutrients with dietary fat can be grouped as to
the site at which they occur: luminal, mucosal, and post absorptive events
(Lukaski 2000). Interactions of fatty acids with calcium and magnesium occur
within the intestinal lumen. Also, interaction between fatty acids and copper
and/or zinc in the intestinal lumen or at the cell membrane has been suggested,
but not extensively studied (Lukaski 2000). There has been an association
demonstrated between dietary fat and iron on non-heme iron absorption, iron
status, and enterocyte aconitase activity (Droke and Lukaski 1996). However,
the influences of fat are less well defined or understood (Lukaski 2000). Heme-
iron is better absorbed by humans than non-heme iron (Hallberg 1981). Efforts
to identify the mechanism by which meat promotes heme iron absorption have
been extensive (Bjorn-Rasmussen and Hallberg 1979) (Hazell et a!. 1978).
However, consistent conclusions from these studies have not been made
(Lukaski 2000). Increasing the saturation of fat. particularly as stearic acid, tends
to favor enhanced absorption of non-heme iron in rats (Bowering et a!. 1977). A
plausible explanation may be the chelation of stearic acid to iron to form stearate-
iron films, which affects the reduction of iron to its more absorbable state, ferrous
iron (Wheeler et a!. 1971). Iron deficiency in rats can be enhanced by the
consumption of unsaturated fat (primarily linoleic acid sources), and retarded by
the consumption of saturated fat diets (Johnson et a!. 1987). Other research also
indicates saturated fat sources such as coconut oil can raise hemoglobin and
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liver iron in rats compared with PUFAs sources such as safflower oil (Johnson et
al. 1992). Recent findings reveal that olive oil, high in monounsaturated fatty
acids, can reduce the blood levels of lipid peroxides and the blood levels of non-
heme iron (Chetty et al. 1999). Plausible explanations may be due to olive oil's
increased mobilization to the liver, which will lower circulating iron (Chetty, et al.
1999). This reduced level of peroxides in the blood can help to lower the
incidences of atherosclerosis in patients that consume high olive oil diets (Chetty,
et al. 1999).
Literature Review Conclusions
Because the interaction between iron and immunity may be confounded
by dietary fat, it is important to identify correlates of iron and dietary fat
interactions on bioavailability to aid in the interpretation of their interactions with
the immune system. The aim of this study was to determine if the type of dietary
fat; monounsaturated, polyunsaturated or saturated, altered immune function in
growing male rats deficient, adequate or overloaded in iron. The study of these






A randomized complete block design with a 3 x 4 factorial arrangement of
treatments was used for this study. The treatments consisted of different dietary
iron concentrations: 10 (iron deficient - FeD), 35 (iron adequate - FeA), or 100
r
(iron high - FeH) ~g/g in combination with different types of dietary fat safflower
oil (SO), flaxseed oil (FO), olive oil (00) or beef tallow (BT). The fat sources
were chosen based on their content of n-3, n-6, and n-9 polyunsaturated fatty
acids and stearic acid (Figure 1).
Animals and Diets
A rapidly growing male rat has an increased demand for iron; making it
possible to induce ir~n deficiency with diet. Therefore, male weanling rats were
used as the model for this study. One hundred and six male weanling Sprague-
Dawley rats (Sasco, Inc., Omaha, NE) were grouped by weight and randomly
assigned to one of thirteen groups, (12 treatment groups, 8 rats/group, and one
baseline group, 10 rats in group).
The rats were ordered in two groups, with 48 treatment rats and 5
baseline group rats arriving in week 1 and the rest in week 2. Each group was
immediately placed on a depletion diet (FeD-SO; Table 1) for 6 days prior to
initiation of the respective treatment diets to equalize iron status. Rats in the
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baseline group were killed after the 6 d depletion period to obtain initial iron
.
status. The formulation of the diets was based on ·the AIN-93G Purified Diets for
Laboratory Rodents (Reeves et al. I 1993). All treatment diets (Table 2)
contained 4% safflower oil by weight with an additional 11 % consisting of the
respective fat source. This supplied 30% of total energy as fat, which is the level,
recommended for humans for decreased risk of chronic diseases. However, it is
considered a high fat diet for the rat (Reeves et al. 1993). The recommended fat
level for rats is 7% fat by weight. The diets were supplemented with ferric citrate
(J.T. Baker, Phillipsburg, NJ) to meet the iron requirements of each diet. The
recommended dietary iron concentration for growing rats is 35 ppm (Reeves et
al. 1993). Upon completion of mixing each diet batch, samples were taken for
mineral analys~s. Diets were stored frozen in 2.5 kg batches in clean 1-gallon
.,
Zip-Iock@ bags at -20°C to prevent oxidation. An analytical balance was used to
measure diets into appropriate diet color-coded polyethylene cups with
corresponding sealing lids. The diets were measured with deionized washed
measuring spoons accounting for uncertainty error to the hundredth decimal
place and kept at 4°C until used.
Rats were housed individually in stainless steel suspension cages with
free access to deionized water. Rats remained on the experimental diets for 8
weeks. In order to minimize differences in food intake, food intake was measured
two times per week. The food intake of all groups was matched to the food
intake of the FeD/SO fed rats (Droke and Lukaski 1996). Equalization of food
intake was needed to eliminate food intake as a variable for body weight and
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immune function differences. Body weight was measured twice weekly
r
accounting for uncertainty error to the tenth decim~1 place. All procedures
involving animals was approved by the Oklahoma State University Laboratory
Animal Care Committee (Appendix A).
Sample Collection and Analyses
All reagents were purchased from Sigma Chemical Co. (St. Louis, MO)
unless otherwise stated. Double distilled nitric acid was purchased from GFS
(Columbus, OH). Ultrapure 30% hydrogen peroxide was purchased from J.T.
Baker (Phillipsburg, NJ).
Rats were killed (1 rat/treatment/d) according to their weight group.
Following an overnight fast in which rats were housed in metabolic cages, they
were anesthetized with Metofane® (Schering-Plough Animal Health, Union, NJ)
and then exsanguinated via the abdominal aorta. Blood samples were collected
for hematological and nutritional analyses. An EDTA-coated syringe was used
for hematological determinations. A citrate-coated syringe was used for plasma
mineral determinations. A syringe with no anticoagulant was used to collect
serum. After centrifugation of the serum in the syringe, the serum was aliquoted
into tubes and stored at -20°C until analyzed. The spleen was excised, and
placed in a pre-weighed tube with 5mL sterile calcium-and-magnesium-free
Hanks' Balanced salt solution (HBSS) for splenocyte isolation. Following
removal of the spleen, the liver, kidney and heart, were removed, rinsed in 0.9%




Before storage, the liver was separated into lobes and the biggest lobe was used
for mineral analyses.
Hematocrit (Hct), hemoglobin (Hgb), white blood cell counts (WBC),
differential leukocyte counts and red blood cell (RBC) measurements were
measured using a ABX-Veg'a Hematology Analyzer (France). Using the mean
values of the baseline group, a change in Hgb and Hct was calculated over time
using hemoglobin regeneration as an index of iron utilization (Wienk et al. 1999).
Serum iron, unsaturated iron binding capacity (UIBC), and total cholesterol, HDL
cholesterol and triacylglycerides parameters were measured using a Cobas Fara
II clinical analyzer (Montclair, NJ). Total iron binding capacity (TIBC) and
transferrin saturation were calculated from the serum iron/UIBC measurements.
Non HDL-cholesterol was calculated from total cholesterol, HDL and
triacylglycerides. Plasma and tissue minera.! content were determined after wet
ashing with ultrapure nitric acid, deionized water and hydrogen peroxide (Hill et
al. 1986) and drY ashing using a Lindberg ashing oven (Wisconsin). All materials
used for the mineral analysis were acid-washed in a 10% hydrochloric acid
solution for twenty-four hours. After washing, materials were then rinsed with
deionized water and dried in a clean oven set at 40°C. The mineral
concentrations were measured using a Perkin Elmer Model 5100 Atomic
Absorption Analyzer (Norwalk, CT). Bovine liver standard (National Institute of
Standards and Technology, Gaithersberg, MD) was analyzed for mineral
concentrations as a quality control measure. The intra-assay and inter-assay
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values were 245.5 ± 26.2 mg Fe per kg sample and 259.3 ± 50.6 mg Fe per kg
sample, respectively.
Isolation of Splenocytes, Lymphocyte Proliferation and Cytokine Production
Using aseptic technique in a laminar flow hood, spleens were transferred
from the tube into a petri .dish and gently teased apart with sterile needles to
obtain single cell suspensions. With a sterile polyethylene disposable transfer
pipette, the spleen tissue/cell mixture was rinsed with HBSS to further disperse
cells into solution. Cells were then fittered (40~m Nylon sterile Falcon filters from
Becton Dickinson, Franklin Lakes, NJ) and diluted with 20 mL of HBSS in a 50
mL polypropylene tube. Five-milliliter cell suspensions were layered onto 5 mL of
Histopaque and centrifuged for 30 minutes at 1000 rpm at room temperature.
Cells at the density interface were removed and washed twice with 12 mL HBSS
in a sterile 15 mL polypropylene tube. Cells were counted and resuspended at 2
x 106 viable cells/mL in RPMI 1640 medium containing 100 ~mL penicillin, 100
}lg/mL streptomycin, and 2 mM L-glutamine. Cell counts and viability were
determined by trypan blue exclusion (0.1 % trypan blue, Eastman Kodak,
Rochester, NY) and counting in a hemacytometer (Helyar and Sherman 1992).
Isolated splenocytes were then aliquoted in 50 Jl:L RPMI into 96-well tissue
culture plates (2 x 105 cells/well). Autologous serum (final concentration, 2%)
was used to stimulate in vivo conditions. The cells were then stimulated with
either a final concentration of 5 ~g/mL or 10 ~g/mL eonA; RPMI alone served as
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the unstimulated control for basal proliferation and cytokine production. Cells
.
were incubated at 37°C for 48 h in a humidified incubator with 5% C02 I 95% air.
Following incubation with mitogen, all wells designated for cell proliferation
had 1 /lei of [methyl- 3H]thymidine (6.7 Ci/mmol; NEN Life Science Products,
Boston, MA) added and incubated for an additional 24 h (Calder et aI., 1995).
After incubation cells were harvested onto glass fiber filter paper discs using a
Skatron Micro 96 cell harvester unit (Norway). Cellular uptake of 3H-thymidine
was quantified through liquid scintillation counting.
Following incubation for 72 hours, the cells designated for cytokine
determination were centrifuged to collect supernatant (pooled from 96-well tissue
culture plates) and the supernatant samples were then frozen at -20°C until used
for cytokine measurements. The supernatant was then thawed, gently vortexed,
and analyzed quantitatively for IL-2 using an enzyme-linked immunosorbent
assay (ELISA) kit (Pharmingen, San Diego, CA).
Further investigation of cytokine production was performed during a
subsequent animal study (approximately one year later). Animals, diets and
procedures of the second study were similar to the present study. Splenocytes
were isolated, placed into 24-well tissue culture plates (1 x 106) and stimulated
with concanavalin A (5 /lg/mL final concentration) or lipopolysaccharide (5 /lg/mL
final concentration); RPMI plus serum alone was used as an unstimulated
control. Interleukins -2, -4, -10 and IFN-y were determined by ELISA kits (IFN-y:











Data were analyzed for a mixed model using SAS (Version 7.0 SAS
Institute Inc., Cary, NC). The random effects variable was the weight group.
Lymphocyte proliferation, serum Fe, tissue and plasma mineral values were log
transformed prior to statistical analyses. Tukey's multiple-comparison procedure
was used to compare individual treatment means. Differences were considered
significant at p < 0.05. The data are presented as the least square means ±
standard error of the mean; log transformed data are presented as the back
transformed mean.
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Choline bitartrate ~41.1 % choline) 2.5
Mineral mix ~iron) 35
AIN-93G-VX 10
Safflower oil 70
,Dietary ingredients were purchased from Harlan Teklad (Madison, WI).
2Mineral mix (g/kg): CaC03, 357; KH2P04, 196; K Citrate, 70.78; NaCI, 74;
KS04, 46.6; MgO, 24; ZnC03, 1.65; MnC03. 0.63; CuC03, 0.3; KI03 , 0.01;
Na Selenate, 0.01025; NH4 Paramolybdate, 0.00795; Na meta-silicate,
1.45; CrKS04, 0.275; LiCI, 0.0174; Boric Acid, 0.0815; NaF, 0.0635;
NiC03, 0.0318; NH4Vanadate, 0.0066; Powdered Sucrose, 218.615.
3Vitamin mix
Table 2: Composition of Experimental Diets
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Figure 1: Fatty acid composition of fat sources based on data




After the 8 weeks on treatment diets, rats fed FeD diets had decreased
(p<0.05) weight gain and food intake compared with rats fed FeA or FeH (Table
3). No differences (p>0.05) in weight gain or food intake were found between
FeA or FeH or among the various sources of dietary fat. An interaction between
iron and fat also was not observed (p>0.05) for either weight gain or food intake.
Iron intake was affected (p<0.05) by dietary iron, which confirms that we fed rats
varying levels of iron (0.23 ± 0.01, 0.75 ± 0.01, 1.92 ± 0.01 Ilg/g; respectively: 10,
35, 100 Ilg/g Fe). Olive oil and SO fed rats had the lowest iron intake. whereas
8T fed rats had the highest iron intake (SO, 0.96 ± 0.014; Fa. 1.00 ± 0.016; 00,
0.87 ± 0.015; BT, 1.03 ± 0.015 mg/d). Analysis of diet samples, indicated the 00
and SO diets had a lower (p<0.05) iron content compared with BT (data not
shown).
Spleen weight as a percentage of body weight (Table 3) was greater
(p<0.05) in FeD rats compared with rats fed FeH, but was not different (p>0.05)
from rats fed FeA. Kidney weights as a percentage of body weight (Table 3)
were reduced (p<0.05) in FeD rats compared with FeA rats. Kidney weights
were similar (p>0.05) between rats fed FeA and FeH. Dietary iron did not affect
(p>0.05) liver weight (data not shown). Spleen weights in rats fed 00 was
greater (p<0.05) than in rats fed SO (spleen: 80,0.243 ± 0.008; FO, 0.253 ±
0.009; 00, 0.275 ± 0.009; BT, 0.245 ± 0.009 %). liver weight as a percentage
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of body weight was reduced (p<0..05) in rats fed SO or Fa compared with 00
(liver: SO, 2.92 ± 0.17; Fa, 2.74 ± 0.17; 00, 3.28 ± 0.17; BT, 3.05 ± 0.17%).
Rats fed 00 or BT had similar (p>0.05) liver weights, as did rats fed BT or SO.
Fat did not affect (p>0.05) kidney weights. Heart weights were affected (p<0.05)
by an iron and fat interaction (Table 4). Heart weights were greater (p<0.05) in
rats FeD with SO, Fa or 00 compared with rats fed FeH with SO, Fa, 00.
Heart weights in rats fed BT were unaffected (p>0.05).
An FeD diet reduced (p<0.05) Hemoglobin (Hgb), Hematocrit (Hct),
erythrocyte counts, and mean corpuscular volume (MCV) (Table 5). Reticulocyte
counts were greater (p<0.05) in rats fed FeD compared with rats fed FeH.
Reticulocyte counts in FeA rats was not measured. Safflower oil fed rats had
reduced (p<0.05) Hgb and Hct compared with BT fed rats (Hgb: SO, 11.7 ± 0.2;
Fa, 11.9 ± 0.2; 00, 11.9 ± 0.2; BT, 12.2 ± 0.2 g/dL; Hct: SO, 32.0 ± 0.4; Fa,
,
32.6 ± 0.4; 00. 33.2 ± 0.4; BT. 33.6 ± 0.4 g/dL). An FeD diet reduced (p<O.05)
serum iron concentration, UIBC, TIBC, and transferrin saturation compared with
FeA or FeH diets (Table 6). No differences (p>0.05) were observed between rats
fed FeA or FeH. Effects of dietary fat or the interaction between dietary iron and
fat were not observed (p>0.05) among treatment groups for these indices of iron
status.
Iron utilization (change in Hgb) was decreased (p<O.05) in rats fed FeD
compared with rats fed FeA or FeH (Figure 2). Rats fed FeD were unable to
regenerate Hgb; whereas. rats fed FeA or FeH exhibited a positive change in
Hgb. Safflower oil tended (p=0.06) to reduce iron utilization (change in Hgb)
{
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compared with BT. Iron utilization was unaffected (p>0.05) by a dietary fat and
iron interaction.
Liver iron concentrations decreased (p<0.05) linearly with decreasing
dietary iron (Figure 3). Total liver iron was also reduced (p<0.05) with lower
dietary iron (1017 ± 189,3191 ± 172, 4849 ± 170 f..l.g Fe; respectively, for 10, 35,
and 100 Ilg/g). Copper concentrations in the liver was lower (p<0.05) in rats fed
FeD compared with rats fed FeH. Liver manganese concentrations were lower
(p<0.05) in rats fed FO compared with rats fed 00 (SO, 9.9 ± 1.0; FO, 9.2 ± 1.0;
00, 10.7 ± 1.0; BT, 10.2 ± 1.0 Ilg/g). No differences (p>0.05) were observed
among the other fat sources. Dietary iron did not affect (p>0.05) liver
concentrations of zinc, calcium and magnesium (data not shown). The
interaction between dietary iron and fat did not have an affect (p>0.05) on liver
mineral concentrations.
Kidney iron concentrations were lower (p<0.05) in FeD rats compared with
rats fed FeA or FeH (Table 7). Kidney copper concentrations were greater
(p<0.05) in rats fed FeA compared with rats fed FeD. Dietary iron did not affect
(p>0.05) kidney concentrations of zinc, calcium or magnesium (data not shown).
Dietary fat or the interaction between dietary iron and fat did not affect (p>0.05)
kidney mineral concentrations.
Heart iron concentrations were reduced in (p<0.05) in rats fed FeD
compared with rats fed FeA or FeH (Table 7). There was no difference (p>0.05)
between rats fed FeA or FeH. Heart zinc concentrations tended to be greater
(p=O.07) in rats fed FeH compared with rats fed FeD (56.00 ± 1.04, 59.90 ± 1.03,
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62.61 ± 1.03; respectively, for 10, 35 and 100 J.L9/g Fe). Dietary iron did not
affect (p>0.05) concentrations of copper, calcium and magnesium. Dietary fat or
the interaction between dietary iron and fat qid not affect (p>0.05) heart mineral
concentrations.
Plasma copper concentrations were affected (p<O.05) by a dietary iron
and fat interaction (Figure 4). When analyzed for iron effects within fat groups,
significant iron effects were observed only in rats fed SO. Plasma copper was
lower (p<0.05) in rats fed FeH compared with rats fed FeD or FeA. Plasma
copper was similar (p>0.05) between FeD and FeA. When analyzed for fat
effects within fat groups, significant fat effects were observed for rats fed FeH.
Rats fed SO had lower (p<0.05) plasma copper compared with rats fed FO or 8T.
Plasma zinc concentrations were greater (p<O.05) in rats fed 8T compared with
SO and FO (Figure 5). Plasma zinc was unaffected (p>0.05) by dietary iron or
the interaction between iron and fat. Plasma calcium concentrations were
reduced (p<O.05) in rats fed FeA compared with rats fed FeD diets (39.7 ± 1.0,
36.9 ± 1.0, 37.5 ± 1.0 mg/L Fe; respectively, for 10,35, and 100 ~g/g). Rats fed
FeH had plasma calcium concentrations that were not different (p>0.05) from
FeD and FeA. Plasma magnesium concentrations were unaffected (p>0.05) by
dietary iron and/or fat.
Total white blood cell counts were unaffected (p>0.05) by dietary iron
and/or fat. An low Fe diet reduced (p<0.05) monocyte and eosinophil
concentrations compared with FeA or FeH (monocyte: 5.6 ± 004, 4.1 ± 004, 3.5 ±
004 %; respectively for 10, 35, 100 ~g/g Fe; eosinophil: 0.63 ± 0.13, 1.33 ± 0.11,
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1.23 ± 0.11 %; respectively for 10, 35, 100 j.1g/g Fe). The FeD diet tended to
reduce (p=0.06) basophil concentrations compared with FeA or FeB (data not
shown). Lymphocyte and neutrophil concentrations were unaffected (p>0.05) by
dietary iron. No differences (p>0.05) were found among dietary fat sources or for
the interaction between dietary iron and fat on these differential leukocyte counts.
Platelet concentrations were greater (p<O.05) in rats fed FeD compared
with rats fed FeA or FeH (Figure 6). No differences (p>0.05) were found among
dietary fat sources or for the interaction between dietary iron and fat on platelet
concentrations.
Total cholesterol, HDL-cholesterol, and non-HDL cholesterol were
.~
unaffected (p>0~.05) by dietary iron and/or fat (data not shown). Flaxseed oil
lowered (p<0.05) triacylglycerides (TG) compared with 00 and 8T; however, it
was not different (p>0.05) from SO (Figure 7). Safflower oil also lowered
(p<0.05) TG compared with 8T. Triacylglycerides were not affected (p>0.05) by
dietary iron or the interaction between dietary iron and fat.
Splenocyte viability was unaffected (p>0.05) by dietary iron and/or fat
(data not shown). Viabilities were greater than 90%. Stimulation of isolated
splenocytes with ConA 5J.1g/mL resulted in higher 3H-thymidine uptake than when
splenocytes were stimulated with GonA 10 j.1g/mL (Figure 8). Rats fed FeD had
suppressed (p<g.05) lymphocyte proliferation, in response to both ConA 5 and
...
10 J.1g/mL compared with rats fed FeA or FeH. Proliferation was not different
(p>0.05) between rats fed FeA or FeH. Splenocyte proliferation in response to




dietary iron and fat (Figure 9). When analyzed for iron effeets within fat groups
differences were obselVed only for rats fed 00. ~ Rats fed FeD had suppressed
(p<O.05) proliferation compared with rats fed FeH. Lymphocyte proliferation in
rats fed FeA was similar (p>O.05) to rats fed FeD or FeH. Within iron groups
rats fed FeH and SO had suppressed (p<O.05) proliferation compared with rats
fed FeH and 00 (4914.7 ± 1.2, 6974 ± 1.2, 7150 ± 1.2,4200 ± 1.2 cpm;
respectively, for SO, FO, 00 and BT).
For both years, IL-2 production by unstimulated cultures was not affected
(p>O.05) by dietary iron and/or fat. Interleukin-2 production (year 1) in response
to ConA 5 ~g/mL tended to be greater (p=0.06) in rats fed FeD compared with
rats fed FeH. Interleukin-2 production in response to ConA 10 Jj.g/mL stimulation
was unaffected (p>0.05) by dietary iron and/or fat. In year two, production of IL-2
in response to stimulation by ConA (5 ~g/mL) lipopolysaccharide was unaffected
(p>O.05) by dietary iron and/or fat.
Production of IL-4 (year 2) in unstimulated cultures was not different
(p>0.05) among groups (data not shown). Interleukin-4 production (year 2) in
response to ConA (5 ~g/mL) stimulation tended to be enhanced (p=0.05) in rats
fed 00 compared with rats fed BT or FO. There was a trend (p=0.08) for an iron
and fat interaction in the ConA stimulated cells.
Interleukin-10 production (year 2) was reduced (p=0.05) in unstimulated
cells of rats fed FeD compared with unstimulated cells of rats fed FeH diets (data
not shown). Production of IL-10 (year 2) in ConA stimulated cultures was not
different (p>O.05) among groups. There was also a strong trend (p=O.07) for IL-
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10 production of lipopolysaccharide stimulated cells to be reduced in rats fed BT,
compared with rats fed FO.
Production of IFN-y (year 2) in unstimulated cultures was not different
(p>0.05) among groups (data not shown). Interferon-y production in response to
GonA tended (p=0.06) to be greater in rats fed FO compared with rats fed SO
(Figure 10). Interferon-y production in response to GonA stimulation was
't
unaffected (p>0.05) by dietary iron or an interaction between iron and fat.
Interferon-y production in response to lipopolysaccharide stimulation was similar




Table 3: Weight gain, organ weights, and food intake in rats fed low, adequate or high iron1
Dietary Spleen weight Kidney weight Heart weight per
Iron Weight gain per body weight per body weight body weight
(Ilg/g) (g) (%) (%) (%)
10 241 ± 5a 0.272 ± 0.009a 0.62 ± 0.01 a 0.394 ± 0.008a
35 254 ± 5b 0.248 ± 0.0088 ,b 0.66 ± 0.01 b 0.335 ± 0.008b,c
100 266 ± 5b 0.242 ± 0.d08b 0.64 ± 0.01 a,b 0.323 ± 0.008c
lValues are presented as the Ismean ±SE (n=7-8).









Table 4: Heart weights, in rats fed low, adequate or high iron with different sources of fat1
Dietary Fat Source 10 J.Lg/g Fe 35 Ilg/g Fe 100 J.Lg/g Fe
Safflower oil 0.409 ± 0.013a 0.325 ± 0.012b 0.322-£ 0:()12D
Flaxseed oil 0.385 ± 0.0148 0.342 ± 0.0138 ,b 0.321 ± 0.013b
Olive oil 0.418 ± 0.0148 0.339 ± 0.013b 0.307 ± 0.013b
Beef Tallow 0.366 ± 0.016 0.333 ± 0.013 0.341 ± 0.013
TValues are presented as the Ismean ± SE (n=7-8).
a,b'Means within a row with unlike letters are different (p<0.05).




Table 5: Hematological data in rats fed low, adequate or high iron1
Dietary Erythrocyte Mean Corpuscular Reticulocyte
Iron Hemoglobin Hematocrit Count Volume Count
(j.!g/g) (g/dl) (%) (100Jrnm3) (1l-rT?) (106/mm3)
10 8.2±0.2a 24.0±0.4a 7.98±0.09a 29.9±OAa 1.17±0.04a
35 13.7 ± O.2b 36.9± OAb 7.39 ± a.08b 50.0 ± OAb " ND2
100 13.9 ± O.2b 37.5 ± 0.3b 7.25 ± 0.08b 51.7 ± 0.3b 0.19 ± 0.04b
lValues are presented as the Ismean ± SE (n=7-8).
2ND = not determined .
a,b,cMeans within a column with unlike letters are different (p<0.05).
s
= _'I. _ \ .:.;,
Table 6: Iron status indicators in rats fed low, ,adequate or high iron1
Dietary Iron Serum Iron2 UIBC3 TIBC Tfs8t
(Ilg /g) (llg/dL) (J.L9/dL) (llg/dL) (%)
10 29 ± 18 480 ± 128 511 ± 88 6 ± 28
35 : 156 ± 1b 290 ± 11 b 453 ± 7b 36 ± 2b
100 169 ± 1b 259 ± 12b 431 ± 8b 40 ± 2b
'Values are presented as Ismean ± SE (n=7-8).
2Serum iron is presented as the back transformed Ismean ± SE.
3UIBC, unsaturated iron binding capacity; TIBC, total iron binding capacity; and,
Tfs8t • transferrin saturation.
a,b,cMeans within a column with unlike letters are different (p<0.05).
Table 7: Kidney and heart mineral concentrations in rats fed low,
adequate or high iron1
Dietary
Organ Iron Iron Copper
(llg1g) (119 /9) (119/g)
Kidney 10 124±18 26±1 8
3'5 254 ± 1b 32 ± 1b
100 276 ± 1b 27 ± 18 ,b
Heart 10 203 ± 1c 17 ± 1
35 287 ± 1d 18 ± 1
100 301±1d 18±1
'Values are presented as the back transformed Ismean ± SE
~=7-8).
a, Kidney means within a column with unlike letters are different (p<0.05).
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Figure 2: Iron utilization with different concentrations of dietary iron or
sources of dietary fat. *Dietary fat source: SO, safflower oil; FO,
flaxseed oil; 00, olive oil; and BT, beef tallow. a.bDietary iron
concentration (n=7-8): bars with unlike letters are different (p<O.05).
c.dDietary fat source (n=7-8): bars with unlike letters are different
(p=O.06)
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Figure 3: Liver mineral concentrations in rats fed low, adequate or
high dietary iron. Values are presented as the back transformed
Ismean with SE. a,b,cLiver iron concentration (n=7-8): bars with unlike
letters are different (p<O.05). d,eLiver copper concentrations (n=7-8):
bars with unlike letters are different (p<O.05).
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Safflower oil Flaxseed oil Olive oil Beef tallow
Figure 4: Plasma copper in rats fed low, adequate or high with
different sources of dietary fat (n=7-8). Values are presented as
the back transformed Ismeans with SE. Dietary Fe and fat
interaction, (p<O.05). a,bBars with unlike letters are different
(p<O.05).
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()'1 Safflower Oil Flaxseed Oil Olive Oil Beef tallow
Figure 5: Plasma zinc in rats fed different sources of dietary fat.
Values are presented as the back transformed Ismean with SE (n=7-












Dietary Iron Concentration (ug/g)
Figure 6: Platelets in rats fed low, adequate or high dietary iron
(n=7-8). a,bBars with unlike letters are different (p<O.05).
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Figure 7: Triacylglyceride concentrations in rats fed different
sources of dietary fat (n=7-8). a,b,cBars with unlike letters are
different (p<O.05).
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ConA-5 ug/mL ConA-10 ug/mL
Figure 8: Mitogen-induced lymphocyte proliferation in rats fed different
concentrations of dietary iron. Cultures were stimulated with
Concanavalin A. Values are presented as the back transformed
Ismeans with SE (n=7-8). a,bConA-5 ug/mL: bars with unlike letters are
different (P<O.05). c,dConA-10 ug/mL: bars with unlike letters are
different (P<O.05).
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Figure 9: Mitage n-induced Iym phocyte proliferation in rats fed different
sources of dietary fat. Cultures were stirn ulated with 5ug/m L
concanavalin A. Values are presented as the back transformed Ismean
with SE for 3H-thymidine uptake in counts per minute (n=7-8). Dietary


























Olive oil Beef tallow
Figure 10: Interferon-y production in response to concanavalin A
stimulation (5 ug/mL) in rats fed different sources of dietary fat.
(n=7-8). Dietary fat (p=0.06).
CHAPTER V
DISCUSSION
Poorer growth rates and food intakes were observed in rats fed a diet
deficient in iron. Even though food intake was restricted to the intake of the
FeD/SO group, differences in food intake and thus iron intake occurred.
Previous studies have indicated iron deficiency can reduce growth (Helyar and
Sherman 1992). Analyses of diets for iron content indicate 8T contained greater
amounts of iron, which may explain why 8T fed rats also had a higher iron intake
compared with SO within iron groups. This opposes another study that found
poor weight gain in rats fed high amounts of stearic acid compared to SO
(Johnson, Lukaski, et al. 1992). However, they fed their source of stearic acid to
rats in the form of free fatty acid; our study fed rats a source of stearic acid in the
form of 8T. 8eef tallow, extruded from animal fat, has been shown to favor
increased absorption of non-heme iron in rats (Bowering et al. 1977). This
mechanism may reflect other studies evaluating the meat factor for promotion of
iron absorption in rats (Bjorn-Rasmussen and Hallberg 1979, Gordon and
Godber 1989). Reduction of food intake, iron intake and growth could be a factor
that could complicate immunological results.
Organ weights as a percentage of body weight varied in rats fed low,
adequate or high iron with different sources offat. Spleen weights were enlarged
in rats fed low iron compared to high iron fed rats. An enlarged spleen size might
implicate increasing the total number of spleen cells compared with normal iron
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status. Corresponding to another study that looked at moderate and sever iron
deficiency in mice our data indicated no significant differences in liver weight
among groups (Helyar and Sherman 1992). Kidney weight was reduced in rats
fed low iron compared to the control rats fed adequate iron. An interaction
between iron and fat was observed in heart weight. Low iron within alf fat
treatments resulted in larger heart weight compared to adequate and high iron
treatments. Enlargement of the heart weight in rats fed low iron could be a factor
that could complicate immunological results.
The various indices of iron status indicate that rats fed FeD had iron
deficiency anemia. The rats fed FeH did not show hematological signs nor tissue
mineral concentrations indicative of iron overload. Hemoglobin, Hct and iron
utilization were reduced with SO (compared with 8T) or with FeD diets. This is
similar to another study indicating that enhancement of iron availability by a
stearic acid source is most important when dietary iron is limiting (Johnson et al.
1992). Safflower oil contains a higher proportion of linoleic acid; whereas 8T
contains a higher proportion of stearic acid. Linoleic acid is known to enhance
iron deficiency compared with stearic acid (Johnson et al. 1987, Amine and
Hegsted 1975). The reduction of iron retention enhanced by safflower oil diets is
thus confirmed by the present study. In contrast to the previous research, iron
utilization was unaffected by an interaction between dietary fat and iron. The
previous research (Droke and Lukaski, 1996; Johnson et al. 1987) used the AIN-
76A diet whereas the present study used the AIN-93G diet formulation, which




used in the present study (30% of total energy); use of a lower level may have
allowed for a detection of an interactive effect on iron utilization.
High iron has been known to reduce both copper and zinc status because
of known competitions during absorption and metabolism (Yu et al. 1994,
Cousins 1985). Plasma and tissue zinc concentrations were not consistently
affected by dietary fat or iron. Plasma, liver and kidney copper concentrations
were decreased with the high iron diet. An iron-copper interaction has previously
been observed in other studies. Increasing intakes of iron reduced status,
absorption and biliary excretion of copper in rats (Yu et al. 1994). This may be
reflective of the proposed mechanism indicating ceruloplasmin, which acts as a
copper-dependent oxidase, works together with a putative basolateral iron
transporter to control the exit of iron out of the enterocyte (Wood and Han 1998).
However, in the plasma, not only were the copper concentrations suppressed in
the high iron fed rats, but specifically in the high iron/safflower oil fed rats,
suggesting that safflower oil may promote the reduction in copper status.
Safflower oil, a polyunsaturated fatty acid may be altering cells membrane fluidity
resulting in altered receptor function that could influence the generation of
intracellular second messengers (Hagve 1988). Changes in copper metabolism
could cause difficulties measuring immune responses. Copper deficiency is
associated with impaired proliferation of T lymphocytes in response to mitogens
(Prohaska and Failla 1993). Evidence suggests that copper may affect the T cell
activation process by altering the transition of the target cell to the competent
stage, which ultimately progresses to its proliferative stage (Failla 1998).
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Total cholesterol, HOl-cholesterol, and non-HOl cholesterol were unaffected by
dietary iron and/or fat. This is unexpected because our study varied the type of
fat to include an n-9, n-6, n-3, and a saturated fat. Variations in the degree of
saturation should result in varied effects on plasma lipids. No significance
differences may resulted from high standard error bars associated with the
Ismeans for each treatment group. On the other hand, triacylglycerides were
significantly different by fat treatments. Flaxseed oil, an n-3 fatty acid had the
lowest TG concentration. Corresponding to other polyunsaturated fatty acid
versus saturated fatty acid studies, this is to be expected (An et al. 1997, Lu et al.
1997). Some experimental animal studies also suggest that n-3 fatty acids not
only lower serum TG levels, but modify the membrane fatty acid composition,
which implicates the reducing effect on the incidence of atherosclerosis and
thrombogenesis (An et a!. 1997, lu et a!. 1997).
Other studies indicate that iron deficiency suppressed lymphocyte
proliferation (Keown et a!. 1984, Helyar and Sherman). Corresponding to these
studies, our data did indicate a lowering effect on proliferation from iron
deficiency. In terms of our hypothesis, our observed data did indicate that iron
deficiency will suppress immune function via suppression of lymphocyte
proliferation. Effects of high iron on lymphocyte proliferation tend to be more
controversial. One study has indicated iron overloading for four weeks on
young rats can increase ConA-stimulated lymphocyte proliferation (Wu et al.
1990). Our data correspond to this study indicating a high iron diet increases
proliferation responses to ConA.
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Splenocyte mitogen-induced lymphocyte proliferation was also
significantly affected by an interaction between dietary iron and fat. A FeH/SO
reduced proliferation compared with a FeH/OO diet. This suggests that cell
proliferation in rats fed FeH is enhanced with 00. Olive oil is a
monounsaturated fatty acid whereas; safflower oil is a polyunsaturated fatty acid.
One possible mechanism that dietary olive oil does not suppress lymphocyte
proliferation when combined with high iron is that olive oil does not suppress the
diacylglycerol or ceramide, which appear to promote T-Iymphocyte proliferation
(Jolly et al. 1997). The high iron may promote the synthesis of arachdonic acid
from linoleic acid. Studies indicate safflower oil or fish oil may suppress the
formation of prostaglandins formed from arachidonic acid. (Jolly et al. 1997)
Others studies have shown that polyunsaturated fatty acids modify lymphocyte
membrane fluidity resulting in altered receptor function that could influence the
generation of intracellular second messengers (Hagve 1988). Perhaps safflower
oil alters splenocyte membrane fluidity so ceramide or diacyglycerol receptors
are formed when high iron is available.
Cytokines that make up the profiles for T-helper-1 and T-helper-2
lymphocytes can be used to measure immune responses. Those cytokines that
represent T-helper-1 (Th1) lymphocytes or IL-2 and INF-y. Interleukin-4 and IL-
10 represent T-helper-2 (Th2) lymphocytes (Von Ruecker and Schmidt-Wolf
2000). Interleukin-2 function to stimulate cell proliferation. Interferon-y
stimulates production of Th1 lymphocytes and suppresses the production of
cytokines originating from Th2 lymphocytes. Interleukin-4, similar to IL-2.
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enhances the proliferation of T lymphocytes, but not to as great of an extent.
Interleukin-1 0 suppresses the production of cytokines and functions of Th 1
lymphocytes. Any alterations to one or more of the cytokines can modify whether
a Th1 or Th2 response predominates. These responses from cytokine could be a
factor in the lymphocyte proliferation results.
Concanavalin A and lipopolysaccharide stimulate not only splenocyte
proliferation but also cytokine production. Dietary iron and fat gave varied results
in response to mitogen stimulation. Iron deficiency did not appear to suppress
cytokine production. A higher iron diet also did not suppress cytokine production.
Flaxseed oil appeared to enhance production of IFN-y, which would suggest a
diminished response from Th2 lymphocytes. Interleukin-4 production appeared
to be enhanced by 00. However, lymphocyte proliferation was similar between
FO and 00. Varied production of cytokines may suggest that diet altered







Weight gain, food intake and various indices of iron status were reduced
by low iron and unaffected by fat and an interaction between dietary iron and fat.
From this data, we can conclude that iron deficiency was established in the
animals fed low iron. However, high iron fed rats did not have indicators of iron
overload except for increased liver iron. Reduction of food intake, iron intake and
growth in animals fed low iron could complicate immunological results.
Iron utilization was reduced with SO compared with 8T. The enhancement
of iron utilization by beef tallow has implications for human diets, because beef
tallow is a source of stearic acid, which is the principal fatty acid in most meat
fats (Johnson et a!. 1992). Agreed, there are differences in iron utilization
between rats and humans; rats absorb less heme iron compared with non-heme
iron, which is contradictory to the relationship found in humans. Nevertheless, a
significant correlation in non-heme iron using the meat factor has been found in
both rats and humans. Unlike previous research, there were no observed
differences in iron utilization for the interaction between dietary iron and fat.
Identical to other studies, plasma copper was affected by iron deficiency.
However, it was also affected by the interaction between dietary iron and fat.
Within SO treatments, high iron reduced copper compared with low and
adequate iron. This interaction could influence the generation of intracellular
secondary messengers, which also could complicate immunological results.
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Liver Manganese concentrations were affected by dietary fat, thus
warranting further investigation into the interaction between dietary fat and
manganese.
Similar to other studies, iron deficiency did suppress lymphocyte
proliferation. However, splenocyte mitogen-induced lymphocyte proliferation was
also significantly affected by an interaction between dietary iron and fat. Within
olive oil treatments, low iron reduced proliferation compared with high iron. This
might suggest that olive oil synergi,stically with low iron further suppresses
proliferation compared with high iron. Within high iron treatments, SO reduced
proliferation compared with 00. This might suggest that 00 enhances immune
responses of high iron fed rats compared to SO; suppression of proliferation was
not observed with high iron compared with adequate iron. Generally, FO, 00,
and BT fed rats had greater enhancement of mitogen-induced lymphocyte
proliferation than SO.
Although lymphocyte proliferation was affected by the interaction between
dietary iron and fat, other immune measurements were not. There was a great
deal, of variation in the effects on mitogen-induced cytokine production by
isolated splenocytes. Little is known about the interaction between dietary fat,
iron and cytokines. However, the finding that cytokines are involved in cellular
proliferation and our findings, suggest that interactions between dietary iron and
fat could be involved in alteration of the cytokines produced by T-helper cells.
Our present findings indicate further research is needed in the area of
nutrient-nutrient interactions and their effect on immune function. Research in
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this area with an immunologically challenged animal would provide further
knowledge on Th1rrh2 cellular activity. In addition. additional immune
measurements should be taken throughout the study to eliminate any adaptation
affect. Since iron overload was not established with the concentration of high
iron used, then there is implication for a study to increase high iron treatments
above 100 Ilg/g of iron in diets. Fat levels might also be adjusted to compare our
findings for 15% fat by weight to the AI N93-G standard of 7% fat by weight.
Identification of other immunological measurements such as interleukin receptors
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